UTHR CFO exercises options, sells 10,000 shares
UNITED THERAPEUTICS Corp CFO and Treasurer James Edgemond reported an exercise-and-sell transaction in company stock.
Rhea-AI Filing Summary
UNITED THERAPEUTICS Corp CFO and Treasurer James Edgemond reported an exercise-and-sell transaction in company stock. He exercised stock options to acquire 10,000 shares of Common Stock at an exercise price of $117.76 per share and, on the same date, sold 10,000 shares of Common Stock in a series of open-market trades at weighted average prices generally around the mid‑$540s to mid‑$550s per share. The filing states that this option exercise and subsequent share sales were carried out under a pre-arranged Rule 10b5‑1 trading plan. Following these transactions, Edgemond directly owns 18,876 shares of UNITED THERAPEUTICS Common Stock.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 10,000 shares ($4.30M approx. pre-tax spread)
Exercise and Sale
11 txns
Insider
EDGEMOND JAMES
Role
CFO AND TREASURER
Sold
10,000 shs ($5.48M)
Approx. gross sale proceeds
$5.48M
Approx. exercise cost
$1.18M
Approx. pre-tax spread
$4.30M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 10,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 10,000 | $117.76 | $1.18M |
| Sale | Common Stock | 1,440 | $544.9599 | $785K |
| Sale | Common Stock | 2,520 | $546.2253 | $1.38M |
| Sale | Common Stock | 1,354 | $547.1116 | $741K |
| Sale | Common Stock | 1,606 | $548.2639 | $881K |
| Sale | Common Stock | 1,185 | $549.2972 | $651K |
| Sale | Common Stock | 1,015 | $550.1955 | $558K |
| Sale | Common Stock | 200 | $550.81 | $110K |
| Sale | Common Stock | 280 | $552.9157 | $155K |
| Sale | Common Stock | 400 | $554.471 | $222K |
Holdings After Transaction:
Stock Option — 40,000 contracts (Direct);
Common Stock — 18,876 shares (Direct)
Footnotes (9)
- F1. This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.
- F2. This transaction was executed in multiple trades at prices ranging from $544.67 to $545.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. This transaction was executed in multiple trades at prices ranging from $545.75 to $546.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $546.75 to $547.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $547.76 to $548.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $548.78 to $549.775. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $549.78 to $550.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $552.76 to $553.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. This transaction was executed in multiple trades at prices ranging from $553.97 to $554.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Shares sold: 10,000 shares
Shares acquired via option exercise: 10,000 shares
Option exercise price: $117.76 per share
+3 more
6 metrics
Shares sold
10,000 shares
Common Stock sold in open-market trades on 2026-06-01
Shares acquired via option exercise
10,000 shares
Common Stock acquired through option exercise on 2026-06-01
Option exercise price
$117.76 per share
Exercise price for 10,000-share stock option
Post-transaction holdings
18,876 shares
Common Stock directly owned after transactions
Option expiration date
2027-03-15
Expiration date of exercised stock option
Net share change from trades
-10,000 shares
Net of 10,000 shares sold and 10,000 shares exercised
Key Terms
Rule 10b5-1 trading plan, stock options, weighted average price, Common Stock, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
stock options financial
"This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
weighted average price financial
"The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Common Stock financial
"security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did UNITED THERAPEUTICS (UTHR) report for CFO James Edgemond?
CFO James Edgemond exercised options and sold shares of UNITED THERAPEUTICS Common Stock. He acquired 10,000 shares through an option exercise and sold 10,000 shares in multiple open-market trades on the same date.
At what price did the UNITED THERAPEUTICS (UTHR) CFO exercise stock options?
He exercised stock options covering 10,000 shares of UNITED THERAPEUTICS Common Stock at an exercise price of $117.76 per share. These options related to a stock option award with an indicated expiration date in March 2027.
Were the UNITED THERAPEUTICS (UTHR) CFO’s trades under a Rule 10b5-1 plan?
Yes. The filing specifies that the option exercise and subsequent sale of shares by the UNITED THERAPEUTICS CFO were executed pursuant to a Rule 10b5-1 trading plan entered into on October 31, 2025, indicating the transactions were pre-scheduled.
AI-generated analysis. How Rhea-AI works. Not financial advice.
